These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28965714)

  • 1. Typhoid vaccine development with a human challenge model.
    Feasey NA; Levine MM
    Lancet; 2017 Dec; 390(10111):2419-2421. PubMed ID: 28965714
    [No Abstract]   [Full Text] [Related]  

  • 2. A conjugate vaccine against typhoid fever.
    Park SE; Marks F
    Lancet Infect Dis; 2014 Feb; 14(2):90-1. PubMed ID: 24290842
    [No Abstract]   [Full Text] [Related]  

  • 3. Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children.
    Mai NL; Phan VB; Vo AH; Tran CT; Lin FY; Bryla DA; Chu C; Schiloach J; Robbins JB; Schneerson R; Szu SC
    N Engl J Med; 2003 Oct; 349(14):1390-1. PubMed ID: 14523155
    [No Abstract]   [Full Text] [Related]  

  • 4. Vi polysaccharide-protein conjugate vaccine for the prevention of typhoid fever in children: hope or hype?
    Pulickal AS; Pollard AJ
    Expert Rev Vaccines; 2007 Jun; 6(3):293-5. PubMed ID: 17542742
    [No Abstract]   [Full Text] [Related]  

  • 5. A Salmonella typhi Vi conjugate vaccine.
    Koul PA
    N Engl J Med; 2001 Aug; 345(7):545-6. PubMed ID: 11519517
    [No Abstract]   [Full Text] [Related]  

  • 6. The immunizing capacity of a five years old dried typhoid vaccine.
    Dimache G; Dimache V; Croitoru M
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):55-9. PubMed ID: 7185349
    [No Abstract]   [Full Text] [Related]  

  • 7. Salmonella enterica serovar Typhi Ty21a expressing human papillomavirus type 16 L1 as a potential live vaccine against cervical cancer and typhoid fever.
    Fraillery D; Baud D; Pang SY; Schiller J; Bobst M; Zosso N; Ponci F; Nardelli-Haefliger D
    Clin Vaccine Immunol; 2007 Oct; 14(10):1285-95. PubMed ID: 17687110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of typhoid somatic-antigen vaccine. III. The rabbit intracutaneous challenge with Salmonella typhi in mucin.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():35-41. PubMed ID: 13886263
    [No Abstract]   [Full Text] [Related]  

  • 9. Host-Salmonella interaction: human trials.
    Levine MM; Tacket CO; Sztein MB
    Microbes Infect; 2001; 3(14-15):1271-9. PubMed ID: 11755415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of typhoid somatic-antigen vaccine. I. Biological studies of Salmonella typhi lysates.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():19-26. PubMed ID: 13886261
    [No Abstract]   [Full Text] [Related]  

  • 11. Specific and cross-reactive immune response to oral Salmonella Typhi Ty21a and parenteral Vi capsular polysaccharide typhoid vaccines administered concomitantly.
    Pakkanen SH; Kantele JM; Savolainen LE; Rombo L; Kantele A
    Vaccine; 2015 Jan; 33(3):451-8. PubMed ID: 25433216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of typhoid somatic-antigen vaccine. II. Serological studies of Salmonella typhi lysates.
    DIENA BB; WALLACE R; GREENBERG L
    Can J Microbiol; 1962 Feb; 8():27-33. PubMed ID: 13886262
    [No Abstract]   [Full Text] [Related]  

  • 13. Antibody response after vaccination against typhoid fever in Kurdish refugee camp.
    Reisinger EC; Grasmug E; Krejs GJ
    Lancet; 1994 Apr; 343(8902):918-9. PubMed ID: 7908379
    [No Abstract]   [Full Text] [Related]  

  • 14. Evolution of the typhoid immunity along one year after intradermal vaccination.
    Dimache G; Croitoru M; Ciordaş C; Velea V
    Arch Roum Pathol Exp Microbiol; 1986; 45(2):147-52. PubMed ID: 3800632
    [No Abstract]   [Full Text] [Related]  

  • 15. Vi Capsular Polysaccharide Produced by Recombinant
    Xiong K; Zhu C; Chen Z; Zheng C; Tan Y; Rao X; Cong Y
    Front Cell Infect Microbiol; 2017; 7():135. PubMed ID: 28484685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific immune responses in typhoid fever & after TAB vaccination.
    Bhaskaram P; Sahay BK; Rao NS
    Indian J Med Res; 1990 Mar; 91():115-9. PubMed ID: 2345018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Appraisal of typhoid vaccine in experimentally infected human subjects.
    Hornick RB; Woodward TE
    Trans Am Clin Climatol Assoc; 1967; 78():70-8. PubMed ID: 6028241
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: outbreak of typhoid fever in vaccinated members of the French Armed Forces in the Ivory Coast.
    Arya SC; Agarwal N
    Eur J Epidemiol; 2006; 21(5):407. PubMed ID: 16721633
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials.
    Bhutta ZA; Capeding MR; Bavdekar A; Marchetti E; Ariff S; Soofi SB; Anemona A; Habib MA; Alberto E; Juvekar S; Khan RM; Marhaba R; Ali N; Malubay N; Kawade A; Saul A; Martin LB; Podda A
    Lancet Infect Dis; 2014 Feb; 14(2):119-29. PubMed ID: 24290843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of purified Vi polysaccharide typhoid vaccine.
    Park JH; Hong JJ; Choi ES; Lee JW; Park JH
    J Vet Sci; 2002 Jun; 3(2):67-70. PubMed ID: 12441674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.